Type 1 diabetes induced by immune checkpoint inhibitors

With the increasing use of immune checkpoint inhibitors (ICI) including anti-cytotoxic T lymphocyte associated antigen-4 (CTLA-4) and anti-programmed cell death-1 (PD-1) in cancers, ICI-induced type 1 diabetes has been reported throughout the world. In this review, we aim to summarize the characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rui, Cai, Xiao-Ling, Liu, Liu, Han, Xue-Yao, Ji, Li-Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722553/
https://www.ncbi.nlm.nih.gov/pubmed/32842016
http://dx.doi.org/10.1097/CM9.0000000000000972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722553/
https://www.ncbi.nlm.nih.gov/pubmed/32842016
http://dx.doi.org/10.1097/CM9.0000000000000972

Ejemplares similares